EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Visceral leishmaniasis in the COVID-19 pandemic era

Anindita Paul, Sushma Singh

Transactions of The Royal Society of Tropical Medicine and Hygiene · 2023

DOI: 10.1093/trstmh/trac100 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transactions of The Royal Society of Tropical Medicine and Hygiene, 2023. Verfasst von Anindita Paul und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, National Institute of Pharmaceutical Education and Research, SAS Nagar, Mohali, Punjab-160062, India. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Visceral l eishmaniasis (VL), also known as kala-azar, had once been targeted for elimination in 2020, which now has been shifted to 2030. The year 2020 was also the year in which the world was gripped by the coronavirus disease 2019 (COVID-19) pandemic. This review sheds light on the impact of COVID-19 on VL elimination programmes and the increasing incidences of COVID-19/VL cases. Lockdowns were imposed worldwide that led to the suspension of surveys, active case finding and mass drug administration, which are important activities to manage neglected tropical diseases. Healthcare machinery was redirected to control the pandemic and acute resource shortages were seen. Budget cuts from funding agencies and donors also came as a severe blow. Priority changes for manufacturers of drugs and diagnostic kits have also exacerbated the situation. Cases where patients were co-infected with VL and COVID-19 were reported across various settings and in people of various age groups, posing unprecedented challenges in diagnosis and treatment. Concerted efforts from all stakeholders are required to understand and deal with the impact that this pandemic has had on VL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, VisceralCOVID-19HumansPandemicsCommunicable Disease ControlMass Drug AdministrationNeglected DiseasesIndia

Stichwörter der Autor:innen

COVID-19co-infectionelimination programmeneglected tropical diseasevisceral leishmaniasis

Autor:innen und Institutionen

  • Department of Biotechnology, National Institute of Pharmaceutical Education and Research, SAS Nagar, Mohali, Punjab-160062, India.

Zitieren

APA

Paul, A., & Singh, S. (2023). Visceral leishmaniasis in the COVID-19 pandemic era. Transactions of The Royal Society of Tropical Medicine and Hygiene. https://doi.org/10.1093/trstmh/trac100

Vancouver

Paul A, Singh S. Visceral leishmaniasis in the COVID-19 pandemic era. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2023. doi:10.1093/trstmh/trac100

BibTeX
@article{Paul2023,
  author = {Paul, Anindita and Singh, Sushma},
  title = {Visceral leishmaniasis in the COVID-19 pandemic era},
  journal = {Transactions of The Royal Society of Tropical Medicine and Hygiene},
  year = {2023},
  doi = {10.1093/trstmh/trac100}
}
Kostenlos starten →